5%+ stake
3.6%Stake · was 6.5%
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Loading…
Traded Aug 22, 2025 · Filed Jan 20, 2026
Charles River Laboratories's Corp Strategy & Develop sold $65K of Charles River Laboratories shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$65,488
Shares × reported transaction price
16 days after results of Aug 6, 2025, 75 days before results of Nov 5, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -4.4% | +1.5% | -5.8% |
| 30 days | -25.5% | +0.6% | -26.1% |
| 90 days | -19.3% | +2.7% | -22.0% |
| 180 days | -3.1% | +8.3% | -11.4% |
Past results only. Not a forecast.
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Compensation award — excluded from discretionary-purchase analysis.
Routine share withholding; mechanical by default.
